Home Stock

Stock Research: Camurus

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Camurus

STO:CAMX SE0007692850
88
  • Value
    4
  • Growth
    69
  • Safety
    Safety
    93
  • Combined
    59
  • Sentiment
    100
  • 360° View
    360° View
    88
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Camurus AB is a Sweden-based pharmaceutical and biotechnology company focused on specialty medicines for severe and chronic diseases. They operate in the pharmaceutical and biotechnology industries, developing products for opioid dependence, pain, cancer, and endocrine diseases. The company is based in Sweden and has legal entities in the US, Germany, UK, Finland, Norway, France, Australia, Spain, Denmark, Austria, and the Netherlands. In the last fiscal year, the company had a market cap of $4186 million, profits of $157 million, revenue of $169 million, and 256 employees.

more

ANALYSIS: With an Obermatt 360° View of 88 (better than 88% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Camurus are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Camurus. The consolidated Growth Rank has a good rank of 69, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 69% of competitors in the same industry. The consolidated Safety Rank at 93 means that the company has a financing structure that is safer than 93% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 100, which means that professional investors are more optimistic about the stock than for 100% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 4, meaning that the share price of Camurus is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 96% of alternative stocks in the same industry. ...read more

more
Strongest Rank Dividend Yield
Weakest Rank Sentiment
Country Sweden
Industry Pharmaceuticals
Size Small
Website camurus.com
Index
Camurus stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 26-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
4 4 1 8
Growth
69 100 95 91
Safety
Safety
93 96 80 34
Sentiment
100 54 76 82
360° View
360° View
88 57 86 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
87 69 78 95
Opinions Change
50 50 72 50
Pro Holdings
n/a 45 53 64
Market Pulse
96 48 39 31
Sentiment
100 54 76 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
4 4 1 8
Growth
69 100 95 91
Safety Safety
93 96 80 34
Combined
59 69 72 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
23 3 5 31
Price vs. Earnings (P/E)
22 14 6 25
Price vs. Book (P/B)
35 3 5 12
Dividend Yield
1 1 1 1
Value
4 4 1 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
87 96 73 90
Profit Growth
44 98 100 78
Capital Growth
98 85 22 93
Stock Returns
14 86 100 20
Growth
69 100 95 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
87 92 90 77
Refinancing
51 25 27 36
Liquidity
94 100 79 8
Safety Safety
93 96 80 34

Similar Stocks

Discover high‑ranked alternatives to Camurus and broaden your portfolio horizons.

Betsson

STO:BETS B
Country: Sweden
Industry: Casinos & Gaming
Size: Medium
Full Stock Analysis

Richter Gedeon

BUD:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Faes Farma

MCE:FAE
Country: Spain
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Ipsen

PAR:IPN
Country: France
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews